BioSpace News Archive

Pharm Country

Caladrius Biosciences to Assess its CLBS201 CD34+ Cell Therapy in Diabetic Kidney DiseaseFDA authorizes new IND for the study of CLBS201 in patients with reduced kidney function

Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), today announced that the U.S. Food and Drug Administration (“FDA”) has authorized its investigational new drug (“IND”) application for the study of CLBS201, a CD34+ cell therapy for the treatment of diabetic kidney disease (“DKD”).

June 22, 2021
·
4 min read
Neurorehabilitation Devices Market: New Multi-electrode Stimulation Proves Efficacious in Treatment of Spinal Cord Injuries

Transparency Market Research has published a new report titled, “neurorehabilitation devices market”.

June 22, 2021
·
6 min read
Medical Cannabis Market: Increase in Use of Cannabidiol (CBD) to Drive Global Market

According to the report, the global medical cannabis market was valued at US$ 8 Bn in 2018 and is projected to grow at a rapid pace from 2019 to 2027.

June 22, 2021
·
5 min read
Rising Prevalence of Cardiovascular Diseases Propelling Acute Care Market Growth: Fact MR Study

Fact MR: The global acute care market is expected to grow at high CAGR in the assessment period, from 2021 to 2031 due to rising demand for treatment of cardio vascular diseases.

June 22, 2021
·
5 min read
Business

OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx

OPKO Health, Inc. announced the appointment of Katherine Stueland as President and Chief Executive Officer of GeneDx, Inc., the global genomics subsidiary of OPKO’s BioReference Laboratories.

June 22, 2021
·
4 min read
Tissue and Organ Transplantation Market Key Players Business Strategies Study Analysis Report

Chronic diseases often lead to catastrophic damage to vital organs. This damage is usually irreversible and leads to lifetime dependency on medicines.

June 22, 2021
·
3 min read